Objective: To estimate the value of skin biopsy in the evaluation of suspected acute cutaneous graft-vs-host dis-ease (GVHD) after allogeneic stem cell transplantation. Design: Decision analysis using parameters specified by expert opinion for skin biopsy characteristics, prevalence of acute GVHD, and value of potential outcomes. One-, 2-, and 3-way sensitivity analyses were performed. Setting: Major stem cell transplantation centers in the United States. Patients: Hypothetical cohort of patients with sus-pected acute cutaneous GVHD after stem cell transplan-tation. Interventions: The following 3 interventions were com-pared: treat immediately for GVHD without performing a skin biopsy, perform a skin biopsy and treat immedi
BackgroundHematopoietic stem cell transplant is a crucial intervention to definitively treat many he...
Skin is usually the first and most affected organ involved in graft-versus-host disease (GvHD), and ...
The mechanisms responsible for skin lesions during acute graft-vs.-host disease (aGVHD) after alloge...
AbstractThe utility of cutaneous biopsies in directing the management of posthematopoietic cell tran...
Background. Acute graft-versus-host disease (aGVHD) involving skin is one of the most frequent compl...
8Introduction: Progress in the transplant procedure has resulted in a higher proportion of patients ...
The graft-versus-host disease is a life-threatening complication of allogeneic bone marrow transplan...
Introduction Graft versus host disease (GVHD) is a major cause of morbidity and mortality following ...
BACKGROUND: Skin biopsy specimens are submitted for rush or stat processing, thereby indicating ...
Background: Skin biopsies are often used in daily practice for the diagnosis of acute (aGvHD) or chr...
Aim: Acute graft-versus-host disease (GVHD) is an complication after allogeneic hematopoietic stem c...
Graft-versus-host disease (GVHD) is an immunological reaction and a frequent complication following ...
Graft-versus-host disease (GvHD) is a major complication following stem-cell or solid-organ transpla...
AbstractA human skin explant model has been used to predict the clinical outcome and to study the im...
A human skin explant model has been used to predict the clinical outcome and to study the immunopath...
BackgroundHematopoietic stem cell transplant is a crucial intervention to definitively treat many he...
Skin is usually the first and most affected organ involved in graft-versus-host disease (GvHD), and ...
The mechanisms responsible for skin lesions during acute graft-vs.-host disease (aGVHD) after alloge...
AbstractThe utility of cutaneous biopsies in directing the management of posthematopoietic cell tran...
Background. Acute graft-versus-host disease (aGVHD) involving skin is one of the most frequent compl...
8Introduction: Progress in the transplant procedure has resulted in a higher proportion of patients ...
The graft-versus-host disease is a life-threatening complication of allogeneic bone marrow transplan...
Introduction Graft versus host disease (GVHD) is a major cause of morbidity and mortality following ...
BACKGROUND: Skin biopsy specimens are submitted for rush or stat processing, thereby indicating ...
Background: Skin biopsies are often used in daily practice for the diagnosis of acute (aGvHD) or chr...
Aim: Acute graft-versus-host disease (GVHD) is an complication after allogeneic hematopoietic stem c...
Graft-versus-host disease (GVHD) is an immunological reaction and a frequent complication following ...
Graft-versus-host disease (GvHD) is a major complication following stem-cell or solid-organ transpla...
AbstractA human skin explant model has been used to predict the clinical outcome and to study the im...
A human skin explant model has been used to predict the clinical outcome and to study the immunopath...
BackgroundHematopoietic stem cell transplant is a crucial intervention to definitively treat many he...
Skin is usually the first and most affected organ involved in graft-versus-host disease (GvHD), and ...
The mechanisms responsible for skin lesions during acute graft-vs.-host disease (aGVHD) after alloge...